The company anticipates that the introduction of Verafeye, with its 4D imaging provision, will usher in a ‘new era’ of ...

These four Dividend Monarch safe-haven stocks offer worried investors lower volatility and defensive characteristics.

Q1 2025 Earnings Call Transcript April 15, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, ...

Johnson & Johnson’s Q1 2025 earnings reveal growth in sales and EPS, boosted by MedTech and Pharma. Click for my updated look at JNJ and its most recent news.

While the top- and bottom-line numbers for Johnson & Johnson (JNJ) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics ...

Good morning, and welcome to Johnson & Johnson's First Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode until the question-and-answer session of the conference. This ...

This story has a lot of personal sentiment and comes from the last words spoken by my brother at the end of 2018, the day he ...

Kaleb Johnson came out of nowhere in 2024 to be one of the most productive running backs in the country behind an excellent ...

For the first quarter of this year, J&J’s total sales of $21.9 billion were up 4.2% over the start of 2024, when accounting ...

Terumo Blood and Cell Technologies, today announced the addition of Patrick Daly as its Chief Business Officer as the company ...

OMP, a global leader in supply chain planning solutions, has been named a Leader in the Gartner Magic Quadrant for the 10th ...

We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...